The Industrial Microbiology Market, estimated at USD 17.96 Bn in 2025, is expected to exhibit a CAGR of 6.4% and reach USD 27.72 Bn by 2032.
The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.
Market players are engaged in increasing product launches, and this is expected to drive the global industrial microbiology market growth. For instance, in August 2025, the Baker Company, Inc., a global company in biosafety and contamination control technology, launched ReCO2ver, a unique new "rapid recovery" cell culture incubator that will provide even more value to its customers' microbiology, cell culture, and biological safety. This innovative "Rapid Recovery Incubator" intended for scientific applications that needs precise control of cell culture conditions, contamination prevention, and maximal cell protection.
Global Industrial Microbiology Market - Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems regarding the transportation of raw materials and manufacturing supplies from one place to another.
Global Industrial Microbiology Market: Key Developments
In September 2025, Eurofins, a global testing company, announced the latest addition to the network of laboratories: a cutting-edge microbiology laboratory in Columbia, Missouri, U.S. The facility is set to revolutionize the field of microbiological testing, catering to the diverse needs of the food, feed, and ingredient industries, as well as providing essential environmental monitoring services.
In July 2025, Neogen Corporation, a food and animal safety company, announced the launch of an improved test system that identifies microorganisms automatically in a quarter of the time required by existing testing methods. The new soleris next generation (NG) from Neogen can identify a wide range of bacteria that might jeopardzse the safety and quality of food and other consumer items.
In February 2025, the UN Environment Program (UNEP), in collaboration with UN-Habitat and IQAir, a Sweden based air quality technology company, launched the world's largest air quality data platform, thus bringing together real-time air pollution data from over 4,000 contributors, including citizens, communities, governments, and the private sector, to work towards healthier, more sustainable cities.